MLV/HIV-pseudotyped vectors: A new treatment option for cutaneous T cell lymphomas

Molecular Therapy

Volumn 8, Issue 5, 2003, Pages 756-761

  Thaler, Sonja ^a   Burger, Angelika M ^a,b   Schulz, Thomas ^a   Schnierle, Barbara S ^a  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FIBRONECTIN; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; RETROVIRUS VECTOR; THYMIDINE KINASE;

ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER STAGING; CELL SPECIFICITY; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFICACY; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; HELPER CELL; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IN VIVO STUDY; LYMPHOPROLIFERATIVE DISEASE; MALE; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; NUDE MOUSE; PHENOTYPE; SUICIDE GENE; T CELL LYMPHOMA; TUMOR GROWTH; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MURINAE; MURINE LEUKEMIA VIRUS; MUS MUSCULUS; SIMPLEXVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0346873026     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(03)00241-7     Document Type: Article

References (15)

1. Diamandidou, E., Cohen, P.R., and Kurzrock, R. (1996). Mycosis fungoides and Sezary syndrome. Blood 88: 2385-2409.
2. Schnierle, B.S., et al. (1997). Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc. Natl. Acad Sci. USA 94: 8640-8645.
3. Thaler, S., and Schnierle, B.S. (2001). A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes. Mol. Ther. 4: 273-279.
4. Kaltoft, K., Bisballe, S., Dyrberg, T., Boel, E., Rasmussen, P.B., and Thestrup-Pedersen, K. (1992). Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides. In Vitro Cell Dev. Biol. 28A: 161-167.
5. Kaltoft, K., Hansen, B.H., and Thestrup-Pedersen, K. (1994). Cytogenetic findings in cell lines from cutaneous T-cell lymphoma. Dermatol. Clin. 12: 295-304.
6. Dobbeling, U., Dummer, R., Laine, E., Potoczna, N., Qin, J.Z., and Burg, G. (1998). Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood 92: 252-258.
7. Aghi, M., Hochberg, F., and Breakefield, X.O. (2000). Prodrug activation enzymes in cancer gene therapy. J. Gene Med. 2: 148-64.
8. Paquin, A., Jaalouk, D.E., and Galipeau, J. (2001). Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications. Hum. Gene Ther. 12: 13-23.
9. Freeman, S.M., Whartenby, K.A., Freeman, J.L., Abboud, C.N., and Marrogi, A.J. (1996). In situ use of suicide genes for cancer therapy. Semin. Oncol. 23: 31-45.
10. Andrade-Rozental, A.F., Rozental, R., Hopperstad, M.G., Wu, J.K., Vrionis, F.D., and Spray, D.C. (2000). Gap junctions: the "kiss of death" and the "kiss of life." Brain Res. Brain Res. Rev. 32: 308-315.
11. Beltinger, C., et al. (1999). Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc. Natl. Acad. Sci. USA 96: 8699-8704.
12. Okimoto, M.A., and Fan, H. (1999). Moloney murine leukemia virus infects cells of the developing hair follicle after neonatal subcutaneous inoculation in mice. J. Virol. 73: 2509-2516.
13. Foss, F.M. (2001). Interleukin-2 fusion toxin: targeted therapy for cutaneous T cell lymphoma. Ann. N. Y. Acad. Sci. 941: 166-176.
14. Deng, H.K., Unutmaz, D., KewalRamani, V.N., and Littman, D.R. (1997). Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388: 296-300.
15. Ory, D.S., Neugeboren, B.A., and Mulligan, R.C. (1996). A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad Sci. USA 93: 11400-11406.